Stability is an important factor in the development of cell lines for therapeutic protein production. In culture, the chromosome number and structure of Chinese Hamster Ovary (CHO) cells undergo rapid change. Over the course of cultivation, selection, and adaptation, chromosomal aberrations such as mutations, deletions, duplications, and other structural variants can accumulate. Some genomic regions may be more prone to such instability than others. When introducing exogenous genes for product formation or for engineering cell characteristics, it is critical to integrate into a stable region. A deeper understanding of the relationship between structure and stability is important for cell culture engineering. We investigated the genome stabi...
AbstractCopy number variation (CNV) is a common chromosomal alteration that can occur during in vitr...
An ideal host cell line for deriving cell lines of high recombinant protein production should be sta...
University of Minnesota Ph.D. dissertation. May 2020. Major: Biomedical Engineering. Advisor: Wei-Sh...
Chinese hamster ovary (CHO) cell line instability that can result in unexpected changes in phenotype...
CHO cells are the number one production system for therapeutic proteins due to their ease of handlin...
Chinese hamster ovary (CHO) cells are the most important platform for producing biotherapeutics. Ran...
Chinese hamster ovary (CHO) cells are the most important platform for producing biotherapeutics. Ran...
Chinese hamster ovary (CHO) cells are the most important platform for producing biotherapeutics. Ran...
Genomic instability in CHO cells poses a challenge for biopharmaceutical production because it is as...
The most striking characteristic of CHO cells is their adaptability, which enables efficient product...
Hertel O. Rationale Entwicklung rekombinanter CHO-Zellen basierend auf Histonanalyse und RNA-Seq: I...
In the current manufacturing platform for large-scale production of therapeutic proteins, recombinan...
Chinese hamster ovary (CHO) cell lines are widely used in the pharmaceutical industry to produce the...
Background: Recombinant cell lines developed for therapeutic antibody production often suffer instab...
Recent advances in genome engineering have opened great opportunities for engineering Chinese hamste...
AbstractCopy number variation (CNV) is a common chromosomal alteration that can occur during in vitr...
An ideal host cell line for deriving cell lines of high recombinant protein production should be sta...
University of Minnesota Ph.D. dissertation. May 2020. Major: Biomedical Engineering. Advisor: Wei-Sh...
Chinese hamster ovary (CHO) cell line instability that can result in unexpected changes in phenotype...
CHO cells are the number one production system for therapeutic proteins due to their ease of handlin...
Chinese hamster ovary (CHO) cells are the most important platform for producing biotherapeutics. Ran...
Chinese hamster ovary (CHO) cells are the most important platform for producing biotherapeutics. Ran...
Chinese hamster ovary (CHO) cells are the most important platform for producing biotherapeutics. Ran...
Genomic instability in CHO cells poses a challenge for biopharmaceutical production because it is as...
The most striking characteristic of CHO cells is their adaptability, which enables efficient product...
Hertel O. Rationale Entwicklung rekombinanter CHO-Zellen basierend auf Histonanalyse und RNA-Seq: I...
In the current manufacturing platform for large-scale production of therapeutic proteins, recombinan...
Chinese hamster ovary (CHO) cell lines are widely used in the pharmaceutical industry to produce the...
Background: Recombinant cell lines developed for therapeutic antibody production often suffer instab...
Recent advances in genome engineering have opened great opportunities for engineering Chinese hamste...
AbstractCopy number variation (CNV) is a common chromosomal alteration that can occur during in vitr...
An ideal host cell line for deriving cell lines of high recombinant protein production should be sta...
University of Minnesota Ph.D. dissertation. May 2020. Major: Biomedical Engineering. Advisor: Wei-Sh...